Literature DB >> 33772888

COVID-19 as a trigger of acute attacks in people with hereditary angioedema.

Aude Belbézier1, Mélanie Arnaud1, Isabelle Boccon-Gibod1,2, Fabien Pelletier2,3, Chloé McAvoy4, Delphine Gobert2,4, Olivier Fain2,4, Aurélie Du-Thanh2,5, David Launay2,6, Julien Lupo7, Laurence Bouillet1,2.   

Abstract

Acute attacks could occur during the convalescent phase of COVID-19 illness, more commonly in patients with a history of frequent attacks. However it is unclear whether the acute attacks during the convalescent phase are specifically triggered by COVID-19 or not.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID-19; HAE; angiotensin-converting enzyme inhibitor; hereditary angioedema

Year:  2021        PMID： 33772888     DOI： 10.1111/cea.13870

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


  3 in total

1.  Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK.

Authors:  Adrian M Shields; Ariharan Anantharachagan; Gururaj Arumugakani; Kenneth Baker; Sameer Bahal; Helen Baxendale; William Bermingham; Malini Bhole; Evon Boules; Philip Bright; Charu Chopra; Lucy Cliffe; Betsy Cleave; John Dempster; Lisa Devlin; Fatima Dhalla; Lavanya Diwakar; Elizabeth Drewe; Christopher Duncan; Magdalena Dziadzio; Suzanne Elcombe; Shuayb Elkhalifa; Andrew Gennery; Harichandrana Ghanta; Sarah Goddard; Sofia Grigoriadou; Scott Hackett; Grant Hayman; Richard Herriot; Archana Herwadkar; Aarnoud Huissoon; Rashmi Jain; Stephen Jolles; Sarah Johnston; Sujoy Khan; James Laffan; Peter Lane; Lucy Leeman; David M Lowe; Shanti Mahabir; Dylan James Mac Lochlainn; Elizabeth McDermott; Siraj Misbah; Fiona Moghaddas; Hadeil Morsi; Sai Murng; Sadia Noorani; Rachael O'Brien; Smita Patel; Arthur Price; Tasneem Rahman; Suranjith Seneviratne; Anna Shrimpton; Catherine Stroud; Moira Thomas; Katie Townsend; Prashantha Vaitla; Nisha Verma; Anthony Williams; Siobhan O Burns; Sinisa Savic; Alex G Richter
Journal:  Clin Exp Immunol       Date:  2022-09-29       Impact factor: 5.732

2.  Effect of COVID-19 on hereditary angioedema activity and quality of life.

Authors:  Ozge Can Bostan; Gulseren Tuncay; Ebru Damadoglu; Gul Karakaya; Ali Fuat Kalyoncu
Journal:  Allergy Asthma Proc       Date:  2021-09-01       Impact factor: 2.587

3.  The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.

Authors:  Marcus Maurer; Markus Magerl; Stephen Betschel; Werner Aberer; Ignacio J Ansotegui; Emel Aygören-Pürsün; Aleena Banerji; Noémi-Anna Bara; Isabelle Boccon-Gibod; Konrad Bork; Laurence Bouillet; Henrik Balle Boysen; Nicholas Brodszki; Paula J Busse; Anette Bygum; Teresa Caballero; Mauro Cancian; Anthony J Castaldo; Danny M Cohn; Dorottya Csuka; Henriette Farkas; Mark Gompels; Richard Gower; Anete S Grumach; Guillermo Guidos-Fogelbach; Michihiro Hide; Hye-Ryun Kang; Allen P Kaplan; Constance H Katelaris; Sorena Kiani-Alikhan; Wei-Te Lei; Richard F Lockey; Hilary Longhurst; William Lumry; Andrew MacGinnitie; Alejandro Malbran; Inmaculada Martinez Saguer; Juan José Matta Campos; Alexander Nast; Dinh Nguyen; Sandra A Nieto-Martinez; Ruby Pawankar; Jonathan Peter; Grzegorz Porebski; Nieves Prior; Avner Reshef; Marc Riedl; Bruce Ritchie; Farrukh Rafique Sheikh; William B Smith; Peter J Spaeth; Marcin Stobiecki; Elias Toubi; Lilian Agnes Varga; Karsten Weller; Andrea Zanichelli; Yuxiang Zhi; Bruce Zuraw; Timothy Craig
Journal:  World Allergy Organ J       Date:  2022-04-07       Impact factor: 5.516
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.